tirofiban

Known as: Tirofibanum, tirofiban [Chemical/Ingredient], N-(butylsulfonyl)-O-(4-(4-piperidyl)butyl)-L-tyrosine 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1996-2018
02040608019962018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
BACKGROUND Patients with a recently implanted coronary drug-eluting stent (DES) who need urgent surgery are at increased risk of… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
BACKGROUND The most effective magnitude and timing of antiplatelet therapy is important in patients with acute ST-elevation… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
CONTEXT Abciximab infusion and uncoated-stent implantation is a complementary treatment strategy to reduce major adverse cardiac… (More)
  • figure 1
  • table 1
  • table 2
  • table 2
  • figure 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
CONTEXT Bare-metal stenting with abciximab pretreatment is currently considered a reasonable reperfusion strategy for acute ST… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2003
2003
Platelet GPIIb/IIIa antagonists are not only used to prevent platelet aggregation, but also in combination with thrombolytic… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
AIMS We evaluated the TIMI Risk Score for Unstable Angina and Non-ST Elevation Myocardial Infarction for predicting clinical… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Acute thrombocytopenia is a recognized complication of treatment with GPIIb/IIIa inhibitors whose cause is not yet known. We… (More)
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND There is continued debate as to whether a routine, early invasive strategy is superior to a conservative strategy for… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND In the setting of percutaneous coronary revascularization, agents in the class known as platelet glycoprotein IIb/IIIa… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
BACKGROUND A major challenge for physicians is to identify patients with acute coronary syndromes who may benefit from treatment… (More)
Is this relevant?